calendar
9 catalysts · 21 phase 2 completion · 17 phase 1 completion · 9 phase 1 initiation · 9 phase 2 initiation · 5 phase 0 trial completion · 4 phase 3 initiation
next 91 dayslessmore
MonWedFri
9 catalysts · 21 phase 2 completion · 17 phase 1 completion · 9 phase 1 initiation · 9 phase 2 initiation · 5 phase 0 trial completion · 4 phase 3 initiation
Therapy area: Dermatology, Immunology. Indication: Atopic Dermatitis (Atopic Eczema), Plaque Psoriasis (Psoriasis Vulgaris), Systemic Lupus Erythematosus
Therapy area: Immunology. Indication: Liver Transplant Rejection
Therapy area: Immunology. Indication: Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Therapy area: Immunology. Indication: Autoimmune Disorders, Diffuse Cutaneous Systemic Sclerosis, Systemic Sclerosis (Scleroderma)
Therapy area: Cardiovascular. Indication: Ischemic Stroke
Therapy area: Cardiovascular. Indication: Acute Coronary Syndrome, Congestive Heart Failure (Heart Failure), Deep Vein Thrombosis (DVT), Myocardial Infarction, Pulmonary Embolism, Thromboembolic Disease, Thromboembolism, Thrombosis, Unstable Angina, Venous (Vein) Thrombosis, Venous Thromboembolism
Therapy area: Cardiovascular. Indication: Acute Ischemic Stroke
Therapy area: Cardiovascular, Genito Urinary System, Metabolic Disorders. Indication: Cardiovascular Risk Factors, Diabetic Nephropathy, Type 1 Diabetes (Juvenile Diabetes), Type 2 Diabetes
Therapy area: Immunology. Indication: Systemic Lupus Erythematosus